Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sanofi (SNY) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Sanofi (SNY) over the last 17 years, with Q4 2025 value amounting to -$3.3 billion.

  • Sanofi's Net Income towards Common Stockholders fell 165531.31% to -$3.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.3 billion, marking a year-over-year increase of 437241.82%. This contributed to the annual value of $8.8 billion for FY2025, which is 4672.29% up from last year.
  • Latest data reveals that Sanofi reported Net Income towards Common Stockholders of -$3.3 billion as of Q4 2025, which was down 165531.31% from $3.3 billion recorded in Q3 2025.
  • In the past 5 years, Sanofi's Net Income towards Common Stockholders ranged from a high of $12.2 billion in Q4 2022 and a low of -$3.3 billion during Q4 2025
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was $2.4 billion (2021), whereas its average is $2.2 billion.
  • Data for Sanofi's Net Income towards Common Stockholders shows a peak YoY increase of 751383.86% (in 2025) and a maximum YoY decrease of 165531.31% (in 2025) over the last 5 years.
  • Over the past 5 years, Sanofi's Net Income towards Common Stockholders (Quarter) stood at $289.9 million in 2021, then soared by 4125.54% to $12.2 billion in 2022, then crashed by 103.86% to -$472.3 million in 2023, then soared by 59.73% to -$190.2 million in 2024, then plummeted by 1655.31% to -$3.3 billion in 2025.
  • Its last three reported values are -$3.3 billion in Q4 2025, $3.3 billion for Q3 2025, and $3.1 billion during Q2 2025.